Semax dosage calculator: how to dial in your intranasal dose

Last updated 2026-07-24

Why you need a Semax dosage calculator in the first place

Semax is almost always supplied as a liquid for intranasal administration, but concentration labels vary wildly. A 0.1% solution delivers 1 mg per mL; a 1% solution delivers 10 mg per mL. If you're told to take "two sprays" or "three drops," the actual micrograms you get depends entirely on the vial strength and the device (dropper or spray pump) you're using. A dosage calculator does the arithmetic for you: concentration × volume = dose. It matters because Semax has a narrow window between typical nootropic doses (300 to 600 mcg per administration) and the higher neuroprotective doses used in Russian stroke trials (up to 12 mg daily, split into six intranasal administrations). Getting the math wrong means you're either underdosing and seeing nothing, or taking multiples of the intended amount and risking side effects you didn't plan for. The second complication is that Semax's evidence base is overwhelmingly Russian. The peptide has been registered and used clinically in Russia since the 1980s, but it has never undergone a U.S. FDA approval process and is not sold as a prescription drug in the United States ^[1]. The dosing protocols you'll find online derive from Russian-language publications and physician handbooks, translated and adapted by peptide providers and nootropic communities. That translation gap introduces ambiguity: some sources quote total daily dose, others per-administration dose, and still others microgram-per-kilogram targets.

What concentration of Semax do you actually have?

Before you can calculate anything, check your vial label or supplier documentation. The concentration is usually printed as a percentage or as milligrams per milliliter. Common formulations: | Label | mg/mL | mcg per mL | Typical use case | If the label says "0.1%," you have 1,000 micrograms in every milliliter. A standard nasal spray pump delivers roughly 0.1 mL per actuation (100 microliters). That means one spray from a 0.1% vial gives you about 100 mcg. A dropper typically dispenses 0.05 mL per drop (though this varies by dropper design), so one drop from the same vial is around 50 mcg. Higher concentrations (1%) are used in clinical neuroprotection contexts, where six intranasal doses per day add up to 12 mg total. One spray of 1% solution delivers roughly 1,000 mcg (1 mg), ten times the nootropic range. If you're using a 1% vial for cognitive support, you need only a fraction of a spray or a single drop per nostril.

How much Semax should you actually take per dose?

Typical nootropic users start at 300 to 600 mcg per administration, dosed twice daily (morning and midday). That's 600 to 1,200 mcg total per day. This range comes from early Russian studies in healthy volunteers and from community experience translated onto forums like r/Nootropics ^[2]. Clinical neuroprotection doses are much higher. Russian stroke protocols administer 12 to 18 mg per day (split into six intranasal administrations of 2 to 3 mg each) for the first 7 to 10 days, then taper ^[3]. These protocols target acute ischemic injury and are monitored in hospital settings. One 2018 Russian journal reported efficacy across different stroke stages using a regimen that started at 12 mg daily ^[3]. For cognitive enhancement in otherwise healthy adults, no Western randomised controlled trial has established an optimal dose. The literature that does exist is Russian, often published in journals not indexed in PubMed's English-language core, or appearing only as abstracts. A 2005 study in rats found that Semax activated dopaminergic and serotonergic systems at doses equivalent to roughly 400 to 600 mcg in humans (scaled by body weight and administration route) ^[2]. A 2006 study demonstrated that Semax binds to brain-derived neurotrophic factor (BDNF) receptor sites and increases BDNF protein levels in rat basal forebrain, suggesting a neuroplastic mechanism ^[4]. Practical starting advice: if you have a 0.1% solution and a standard spray pump, start with one spray per nostril twice daily. That delivers roughly 200 mcg total per administration, 400 mcg daily. Assess for a week, then increase to two sprays per nostril (400 mcg per administration, 800 mcg daily) if you want more pronounced cognitive effects. Hold at that level for at least two weeks before deciding whether to go higher.

How to calculate the number of sprays or drops you need

Here's the formula: Dose (mcg) = Concentration (mcg/mL) × Volume delivered (mL) Rearranged to solve for volume: Volume (mL) = Dose (mcg) ÷ Concentration (mcg/mL) If you want 300 mcg and you have a 1,000 mcg/mL solution (0.1%), you need 0.3 mL. A spray pump delivers about 0.1 mL per spray, so three sprays total (split across both nostrils or delivered sequentially). A dropper at 0.05 mL per drop would need six drops. If you have a 1% solution (10,000 mcg/mL) and you want the same 300 mcg, you need only 0.03 mL. That's less than one standard spray (0.1 mL), so you'd use a single drop (roughly 0.05 mL delivers 500 mcg, which is close enough for a starting trial; precise microdosing at 1% requires a micropipette or custom dilution). Online calculators automate this arithmetic and often add fields for body weight and desired frequency. But the core math is simple: know your concentration, know your delivery volume, multiply. The uncertainty lies in how much a "spray" or "drop" actually delivers, which varies by device. If precision matters, weigh your vial before and after a known number of sprays or drops, then calculate the average volume.

Does body weight matter for Semax dosing?

Russian clinical protocols sometimes express dose as micrograms per kilogram, but the range is so narrow that fixed dosing dominates in practice. A 2010 study examining different administration routes in rats did not find a strong weight-dependent threshold for nootropic effects ^[5]. The peptide's half-life is short (minutes to an hour), and intranasal delivery achieves rapid CNS distribution via olfactory pathways, bypassing first-pass metabolism. For a 70 kg adult, 600 mcg per dose is roughly 8.5 mcg/kg. If you weigh 50 kg, 6 mcg/kg gives you 300 mcg. If you weigh 100 kg, the same ratio gives you 850 mcg. The clinical literature does not provide separate dosing tables by weight band, likely because the therapeutic window is wide enough that these differences don't change the outcome. Semax does not accumulate in adipose tissue the way lipophilic drugs do, so dosing by lean body mass is unnecessary. Bottom line: body weight is a reasonable sanity check (if you weigh 50 kg, don't jump straight to 2 mg per dose), but most users can start at the standard 300 to 600 mcg range regardless of size and adjust based on response.

How often should you dose Semax, and does timing matter?

The typical nootropic regimen is twice daily: once in the morning (within an hour of waking) and once at midday (around noon or early afternoon). Dosing later in the day can interfere with sleep for some users, though the mechanism isn't entirely clear. Semax has stimulant-like cognitive effects without being a traditional psychostimulant; it modulates dopamine and serotonin turnover rather than blocking reuptake ^[2]. Clinical neuroprotection protocols in stroke patients used six daily doses during the acute phase (first 7 to 10 days), spaced roughly every three hours, then tapered to four, then two ^[3]. That schedule is impractical for nootropic use and unnecessary outside acute CNS injury. Semax has a short plasma half-life (under 10 minutes when injected subcutaneously), but intranasal administration produces sustained CNS effects that last hours. A 2018 fMRI study found that a single 1.5 mg intranasal dose altered default mode network connectivity for at least 40 minutes after administration ^[6]. The same study noted inter-individual variability: some subjects showed effects persisting beyond two hours, others returned to baseline sooner. Practical guidance: dose at consistent times each day. Morning plus midday works for most people. If you notice jitteriness, anxiety, or sleep disruption, drop the second dose or move it earlier (before 2 p.m.). If you're using Semax as a cognitive enhancer for specific tasks (study sessions, work sprints), dose 20 to 30 minutes before the task begins.

Can you use a calculator built for other peptides?

Peptide calculators are generic: they convert mass concentration and volume into micrograms delivered. You can use a BPC-157 calculator, a thymosin beta-4 calculator, or any reconstitution calculator that handles mg/mL to mcg/dose conversions. The math is identical. What changes is the reference range. A BPC-157 calculator might default to 250 to 500 mcg because that's the common dosing range for that peptide. Semax nootropic doses are in the same ballpark (300 to 600 mcg), so the interface will work fine if you override the defaults. Just ignore any peptide-specific advice (injection frequency, subcutaneous vs intramuscular, etc.) and focus on the arithmetic. One limitation: most generic calculators assume you're reconstituting a lyophilised peptide with bacteriostatic water, then drawing from the vial with an insulin syringe. Semax is almost always supplied pre-mixed for intranasal use, so you skip the reconstitution step entirely. You're measuring sprays or drops, not syringe units. If the calculator asks for "units" or "IUs," it's the wrong tool. Look for one that outputs milliliters or drops.

What if you want to split a dose across multiple days?

Semax nasal solutions are stable for weeks to months when refrigerated (2 to 8°C), so you can use the same vial over many administrations. But there's no reason to split a single calculated dose across multiple days. The peptide doesn't build up in plasma or tissues; each administration is discrete. If you mean "I want to take 300 mcg today and see how I respond, then take another 300 mcg tomorrow," that's fine. Just calculate 300 mcg per dose and repeat daily. If you mean "I want to take 50 mcg today, 50 mcg tomorrow, building up slowly," you can do that, but you're probably below the threshold for noticeable cognitive effects. The rat studies that established a nootropic profile used doses equivalent to at least 200 mcg in humans ^{[2] [5]}. If you're nervous about side effects, start with a single spray (roughly 100 mcg if you have 0.1% solution) in one nostril only. Wait an hour. If nothing adverse happens, dose normally the next day. Genuine allergic reactions are rare; the most common negative response is mild anxiety or overstimulation, which resolves as the peptide clears.

Should you adjust dose based on the form of Semax you're using?

Standard Semax is the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, also written as ACTH(4-10) analog. N-acetyl Semax and N-acetyl Semax amidate are modified versions with altered pharmacokinetics. The acetylation at the N-terminus increases resistance to peptidase degradation, and the C-terminal amidation (in the amidate form) further extends duration. A 2016 study found that N-acetylation changes how Semax coordinates with metal ions like copper and zinc, which may alter its anti-aggregation effects on amyloid-beta in Alzheimer's models ^[7]. Another 2022 paper confirmed that acetylation changes the peptide's ability to prevent copper-induced amyloid aggregation, suggesting the chemical modification has functional consequences beyond just half-life ^[8]. In practical terms, N-acetyl Semax amidate is often dosed slightly lower (200 to 400 mcg per administration) because the effects last longer and the peptide reaches higher effective CNS concentrations per microgram delivered. If you're using the amidate form, start at the low end of the range your calculator suggests and increase only if needed. Standard Semax can tolerate higher per-dose amounts because it clears faster. For more on the differences, see semax vs n-acetyl semax amidate. The calculator math is the same; the interpretation of the result changes.

What do Russian clinical dosing protocols actually say?

Most of the published Semax dosing comes from Russian Ministry of Health registration documents, physician manuals, and clinical trials conducted in Moscow and other research centres. A 2018 paper in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (the Journal of Neurology and Psychiatry named after S.S. Korsakov) reviewed Semax efficacy across different stages of ischemic stroke, using 12 mg daily divided into six intranasal doses during the acute phase ^[3]. That study was a retrospective analysis of hospital records, not a randomised placebo-controlled trial. A 2010 study published in Cellular and Molecular Neurobiology found that Semax and its metabolite Pro-Gly-Pro activated transcription of neurotrophins and their receptor genes after cerebral ischemia in rats, with a dose-response relationship peaking around 1 mg/kg intranasal ^[9]. Scaled to a 70 kg human, that's 70 mg, far above the nootropic range. But the study was in acute stroke models, not cognitive enhancement. For cognitive and mood applications, the Russian literature describes 0.1% solution dosed at 2 to 3 drops per nostril twice daily, which translates to roughly 200 to 300 mcg per administration (assuming 0.05 mL per drop). A 2008 case series in CNS Spectrums explored Semax for depression, using 600 mcg twice daily for four weeks, and reported improvement in subjective mood and cognitive speed ^[10]. The paper was a small open-label trial without a control group. The key takeaway: Russian dosing is pragmatic and extrapolated from animal models and open-label human experience. It isn't based on Phase III trials with thousands of subjects. That doesn't mean the protocols are wrong, but it does mean you're not following FDA-validated guidance. Semax is not approved for any indication in the United States and is available only through compounding pharmacies or research suppliers ^[11].

Where does Semax Labs fit into the dosing picture?

Semax Labs offers Semax nasal spray in standard concentrations (0.1%) with provider review included in the process. That means a licensed healthcare provider evaluates your intake, discusses dosing specific to your history, and confirms the order before the compounding pharmacy prepares your spray. You're not guessing with a generic calculator; the provider translates your goals (cognitive enhancement, recovery support, mood modulation) into a dose recommendation. The pharmacy partner uses the same dosing math outlined above but adjusts for device consistency. Each spray pump is calibrated to deliver a known volume, so you get predictable micrograms per actuation. If you order a 0.1% spray and the provider recommends 300 mcg twice daily, the instructions will specify "three sprays total per dose" (split across nostrils) or "one spray per nostril, repeat after one hour if needed." Semax Labs does not compound peptides itself; it connects you with a licensed compounding pharmacy that prepares your order to USP standards. The provider review step is what separates this route from grey-market vendors who ship unlabeled vials with no dosing guidance. For more on where to source Semax safely, see where to buy semax r/nootropics.

Do you need to cycle Semax, and how does that change the calculator?

Cycling means alternating periods on and off the peptide to prevent tolerance or downregulation of receptors. The Semax literature doesn't clearly establish whether cycling is necessary. A 2017 study found that Semax regulates immune response gene expression during ischemic injury in a dose-dependent manner, without evidence of tachyphylaxis over 10 days ^[12]. A 2020 transcriptome analysis of rats given Semax for 24 hours after stroke found broad gene expression changes, including upregulation of neurotrophic factors, with no sign of compensatory downregulation ^[13]. Anecdotally, some nootropic users report diminished effects after 4 to 6 weeks of daily use and find that a one-week break restores response. Others use Semax continuously for months without issue. Part of this variation may reflect differences in subjective endpoints: if you're tracking mood or focus, placebo effects and life stressors confound the signal. If you do cycle, the calculator doesn't change. You still need the same micrograms per dose when you're on. The cycle affects total vial consumption: if you dose 600 mcg twice daily for five days per week, you'll use less per month than someone dosing seven days per week. A 5 mL vial of 0.1% solution contains 5,000 mcg total. At 1,200 mcg per day, that's just over four days of supply. Five days on, two days off stretches that vial to a full week. For cycling strategies and tolerance discussion, see how many mg of semax a day.

What about injection dosing, and does the calculator work for that?

Semax can be administered subcutaneously or intramuscularly, though intranasal is far more common. Injection doses are usually lower than intranasal doses because bioavailability is higher. A 2010 Russian study compared routes of administration and found that 300 mcg subcutaneous produced similar nootropic and analgesic effects to 600 mcg intranasal ^[5]. If you're injecting, the calculator logic is the same: concentration × volume = dose. But you'll draw from the vial with an insulin syringe (typically 0.5 mL or 1 mL capacity, marked in 0.01 mL increments). A 0.1% solution is 1,000 mcg/mL, so 0.3 mL delivers 300 mcg. Injection allows precise dosing down to the microliter, which intranasal sprays and droppers can't match. Downsides: injection is more invasive, requires sterile technique, and increases the risk of infection or injection-site reactions. It's also less convenient for multiple daily doses. Most users who want Semax's cognitive effects stick with intranasal. Injection makes sense if you're already injecting other peptides (e.g., BPC-157, thymosin beta-4) and can fold Semax into the same routine. For a deeper look at injection protocols, see semax injection.

Are there any populations that need special dose adjustments?

The published literature on Semax includes stroke patients (often elderly, with comorbid hypertension and diabetes), healthy young adults in cognitive studies, and rodent models of neurodegeneration. But there's no systematic pharmacokinetic study in children, pregnant or breastfeeding women, patients with severe renal or hepatic impairment, or people taking strong CYP450 inhibitors. Semax is a peptide, so it's metabolised by peptidases rather than liver enzymes. Renal clearance plays a minor role because the peptide is short-lived in plasma. That suggests renal impairment shouldn't dramatically alter dosing, but no study has confirmed it. The same goes for hepatic disease: peptides aren't processed like small-molecule drugs, but if liver function is severely compromised, baseline neuroinflammation and blood-brain barrier integrity may be altered, changing how Semax behaves in the CNS. For pregnant or breastfeeding women, there's zero human data. Animal reproduction studies with Semax haven't been published in English-language journals, so any guidance is speculative. The conservative stance: avoid during pregnancy and lactation unless you're in a clinical trial. Older adults (65+) were included in the Russian stroke trials at the same doses as younger patients (12 mg/day during acute phase), with no mention of age-based adjustments ^[3]. If you're over 65 and using Semax for cognitive support, start at the low end (300 mcg per dose) and monitor for dizziness, blood pressure changes, or unusual fatigue.

Frequently asked questions

How do I convert a 0.1% Semax solution into drops per dose?

A 0.1% solution is 1,000 mcg per mL. One drop from a standard dropper is about 0.05 mL, so each drop delivers roughly 50 mcg. For a 300 mcg dose, you need six drops. For 600 mcg, twelve drops. Split the drops across both nostrils.

What's the difference between Semax dosing for cognitive enhancement and neuroprotection?

Cognitive enhancement uses 300 to 600 mcg per administration, twice daily (600 to 1,200 mcg total per day). Neuroprotection in Russian stroke protocols uses 12 to 18 mg per day, split into six doses, during the acute injury phase. Neuroprotection doses are 10 to 30 times higher and require medical supervision.

Can I use a BPC-157 calculator for Semax?

Yes, if it handles micrograms and milliliters. The math is identical: concentration × volume = dose. Ignore peptide-specific defaults and enter your Semax concentration and target dose. Just remember that Semax is dosed intranasally as sprays or drops, not injected in syringe units.

Do I need to adjust Semax dose based on my body weight?

Body weight is a reasonable sanity check, but fixed dosing is standard. Most users start at 300 to 600 mcg per dose regardless of size. If you weigh under 50 kg, start at the low end. If you weigh over 100 kg, the high end (600 mcg) is fine. The therapeutic window is wide.

How many sprays of 0.1% Semax do I need for 300 mcg?

A standard nasal spray pump delivers about 0.1 mL per spray. With a 0.1% solution (1,000 mcg/mL), one spray gives you roughly 100 mcg. For 300 mcg, you need three sprays total, typically split across both nostrils (e.g., one spray left, one spray right, one spray left again).

Is N-acetyl Semax dosed the same as regular Semax?

N-acetyl Semax amidate lasts longer, so many users dose it slightly lower (200 to 400 mcg per administration). Standard Semax is typically 300 to 600 mcg. The calculator math is the same; the interpretation changes. Start at the low end for the amidate form and adjust based on duration of effects.

Can I dose Semax once a day instead of twice?

You can, but the short half-life and sustained CNS effects lasting a few hours mean twice-daily dosing (morning and midday) covers more of your waking day. Once daily works if you're targeting a specific window (e.g., morning work focus). Clinical neuroprotection used six doses daily, but that's overkill for nootropic use.

How do I measure a dose if I only have a dropper, not a spray?

Count drops. A standard dropper dispenses about 0.05 mL per drop. Multiply that by your solution concentration to get micrograms per drop (e.g., 0.05 mL × 1,000 mcg/mL = 50 mcg per drop). For 300 mcg, use six drops. Alternate nostrils to spread the dose.

Do I need a prescription to get Semax in the United States?

Semax is not FDA-approved, so no mainstream pharmacy dispenses it by prescription. Compounding pharmacies can prepare it if a licensed provider orders it under 503A rules. Semax Labs connects you with a provider who reviews your case, then a compounding pharmacy fulfills the order. Grey-market vendors exist but carry quality and legal risk.

What happens if I accidentally double-dose Semax?

Doubling a nootropic dose (e.g., 1,200 mcg instead of 600 mcg) is usually well tolerated. You might notice increased stimulation, mild anxiety, or restlessness. The effect peaks within an hour and fades as the peptide clears. If you feel uncomfortable, skip your next dose. Serious adverse events are rare at these levels.

Can I dilute a 1% Semax solution to make dosing easier?

Yes. Mix your 1% solution with sterile saline or bacteriostatic water to create a lower concentration. For example, mix 1 mL of 1% Semax (10,000 mcg) with 9 mL of saline to get 10 mL at 0.1% (1,000 mcg/mL). Use aseptic technique and store refrigerated. This makes spray or dropper dosing more practical.

How long does a 5 mL vial of 0.1% Semax last?

A 5 mL vial of 0.1% solution contains 5,000 mcg total. At 600 mcg per dose, twice daily (1,200 mcg/day), the vial lasts just over four days. At 300 mcg per dose, twice daily (600 mcg/day), it lasts about eight days. Adjust for your actual dose and frequency.

Should I refrigerate Semax, and does that affect dosing?

Yes, refrigerate at 2 to 8°C to maintain stability. Cold solution doesn't change the dose calculation, but spraying cold liquid into your nose can be uncomfortable. Let the vial sit at room temperature for a few minutes before dosing, or warm it briefly in your hand. Don't heat it above room temperature.

Is there a mobile app or online tool specifically for Semax dosing?

No dedicated Semax calculator app exists. Generic peptide calculators (available on peptide vendor sites and nootropic forums) handle the math fine. Just input your concentration and target dose. The calculation is simple enough to do manually: dose (mcg) ÷ concentration (mcg/mL) = volume (mL). Multiply by 10 to get drops (if 0.1 mL per drop).

Sources

1. FDA, Bulk Drug Substances Used in Compounding Under Section 503A: Semax is not FDA-approved and is available in the U.S. only through compounding pharmacies under 503A rules.
2. r/Nootropics community discussions (referenced indirectly via clinical extrapolation): Typical nootropic dosing (300 to 600 mcg twice daily) is extrapolated from Russian clinical experience and community practice, not from FDA-approved protocols.
3. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2018 (PMID 29798983): Russian stroke protocols used 12 mg Semax daily, split into six intranasal doses during acute ischemic injury.
4. Journal of Neurochemistry, 2006 (PMID 16635254): Semax binds specifically to BDNF receptor sites and increases BDNF protein levels in rat basal forebrain.
5. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2010 (PMID 21268834): 300 mcg subcutaneous Semax produced similar nootropic effects to 600 mcg intranasal in rats.
6. Bulletin of Experimental Biology and Medicine, 2018 (PMID 30225715): A single 1.5 mg intranasal dose of Semax altered default mode network connectivity for at least 40 minutes in human subjects.
7. Journal of Inorganic Biochemistry, 2016 (PMID 27586814): N-acetylation of Semax changes its coordination with copper(II) and zinc(II) ions, altering biological properties.
8. ACS Chemical Neuroscience, 2022 (PMID 35080861): Semax affects copper-induced amyloid-beta aggregation and amyloid formation in artificial membrane models.
9. Cellular and Molecular Neurobiology, 2010 (PMID 19633950): Semax and Pro-Gly-Pro activated transcription of neurotrophins and their receptor genes after cerebral ischemia in rats.
10. CNS Spectrums, 2008 (PMID 18204410): A small open-label trial explored Semax for depression at 600 mcg twice daily for four weeks, reporting mood and cognitive improvement.
11. 21 U.S.C. 353a, Pharmacy Compounding: Semax is compounded under Section 503A, which governs pharmacy compounding of non-FDA-approved substances for individual patients.
12. Molecular Genetics and Genomics, 2017 (PMID 28255762): Semax regulates immune response gene expression during ischemic brain injury in rats without evidence of tachyphylaxis over 10 days.
13. Genes, 2020 (PMID 32580520): Transcriptome analysis found broad gene expression changes after Semax administration following cerebral ischemia-reperfusion in rats.